Esaxerenone Inhibits Renal Angiogenesis and Endothelial-Mesenchymal Transition via the VEGFA and TGF-β1 Pathways in Aldosterone-Infused Mice

Renal fibrosis is an inevitable process in the progression of chronic kidney disease (CKD). Angiogenesis plays an important role in this process. Vascular endothelial cells are involved in renal fibrosis by phenotypic transformation and secretion of extracellular matrix. Aldosterone stimulates mineralocorticoid receptor (MR) activation and induces inflammation, which is important for angiogenesis. Clinically, MR blockers (MRBs) have a protective effect on damaged kidneys, which may be associated with inhibition of angiogenesis. In this study, we used aldosterone-infused mice and found that aldosterone induced angiogenesis and that endothelial-mesenchymal transition (EndMT) in neovascular endothelial cells was involved in renal fibrosis. Notably, aldosterone induced inflammation and stimulated macrophages to secrete vascular endothelial growth factor (VEGF) A to regulate angiogenesis by activating MR, whereas EndMT occurred in response to transforming growth factor-β1 (TGF-β1) induction and participated in renal fibrosis. These effects were antagonized by the MRB esaxerenone. These findings suggest that reducing angiogenesis may be an effective strategy for treating renal fibrosis.

[1]  Fan Yang,et al.  Eplerenone inhibits the macrophage-to-myofibroblast transition in rats with UUO-induced type 4 cardiorenal syndrome through the MR/CTGF pathway. , 2022, International immunopharmacology.

[2]  Gege Chen,et al.  Eplerenone Prevents Cardiac Fibrosis by Inhibiting Angiogenesis in Unilateral Urinary Obstruction Rats , 2022, Journal of the renin-angiotensin-aldosterone system : JRAAS.

[3]  Fan Yang,et al.  Esaxerenone inhibits the macrophage-to-myofibroblast transition through mineralocorticoid receptor/TGF-β1 pathway in mice induced with aldosterone , 2022, Frontiers in Immunology.

[4]  S. Adler,et al.  Dual therapy with an angiotensin receptor blocker and a JAK1/2 inhibitor attenuates dialysate-induced angiogenesis and preserves peritoneal membrane structure and function in an experimental CKD rat model , 2022, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[5]  Jun Wang,et al.  Dioscin Reduces Vascular Damage in the Retina of db/db Mice by Inhibiting the VEGFA Signaling Pathway , 2022, Frontiers in Pharmacology.

[6]  Manhua Chen,et al.  Resveratrol Ameliorates Cardiac Remodeling in a Murine Model of Heart Failure With Preserved Ejection Fraction , 2021, Frontiers in Pharmacology.

[7]  S. Mu,et al.  Eplerenone Attenuates Fibrosis in the Contralateral Kidney of UUO Rats by Preventing Macrophage-to-Myofibroblast Transition , 2021, Frontiers in Pharmacology.

[8]  K. Wollert,et al.  Angiogenesis After Acute Myocardial Infarction. , 2020, Cardiovascular research.

[9]  Afei Zhang,et al.  Role of VEGF-A and LRG1 in Abnormal Angiogenesis Associated With Diabetic Nephropathy , 2020, Frontiers in Physiology.

[10]  E. Schiffrin,et al.  Aldosterone, Inflammation, Immune System, and Hypertension , 2020, American journal of hypertension.

[11]  N. Frangogiannis,et al.  "Extracellular matrix-derived peptides in tissue remodeling and fibrosis". , 2020, Matrix biology : journal of the International Society for Matrix Biology.

[12]  L. G. Vu,et al.  Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 , 2020, The Lancet.

[13]  Lei Cao,et al.  B7-H3 promotes colorectal cancer angiogenesis through activating the NF-κB pathway to induce VEGFA expression , 2020, Cell Death & Disease.

[14]  I. Berindan‐Neagoe,et al.  Hypoxia: Overview on Hypoxia-Mediated Mechanisms with a Focus on the Role of HIF Genes , 2019, International journal of molecular sciences.

[15]  Xianzhong Xiao,et al.  VEGF‐A promotes angiogenesis after acute myocardial infarction through increasing ROS production and enhancing ER stress‐mediated autophagy , 2019, Journal of cellular physiology.

[16]  Yuting Zhou,et al.  Procyanidin B2 inhibits the activation of hepatic stellate cells and angiogenesis via the Hedgehog pathway during liver fibrosis , 2019, Journal of cellular and molecular medicine.

[17]  Sarah L. Doyle,et al.  IL-1 Family Cytokine Regulation of Vascular Permeability and Angiogenesis , 2019, Front. Immunol..

[18]  N. Hukriede,et al.  The role of macrophages during acute kidney injury: destruction and repair , 2019, Pediatric Nephrology.

[19]  K. Wu,et al.  Update of pathophysiology and management of diabetic kidney disease. , 2018, Journal of the Formosan Medical Association = Taiwan yi zhi.

[20]  A. Nakashima,et al.  Na+-Cl- cotransporter-mediated chloride uptake contributes to hypertension and renal damage in aldosterone-infused rats. , 2018, American journal of physiology. Renal physiology.

[21]  Q. Hao,et al.  IL‐27 regulates HIF‐1&agr;‐mediated VEGFA response in macrophages of diabetic retinopathy patients and healthy individuals , 2018, Cytokine.

[22]  D. Stevenson,et al.  Hypoxia regulates placental angiogenesis via alternatively activated macrophages , 2018, American journal of reproductive immunology.

[23]  E. Boerwinkle,et al.  CD163+ macrophages promote angiogenesis and vascular permeability accompanied by inflammation in atherosclerosis , 2018, The Journal of clinical investigation.

[24]  E. Lushnikova,et al.  Immunohistochemical Study of the Expression of Vascular Endothelial Growth Factor Receptor-2 (KDR/Flk-1) during Myocardial Infarction , 2017, Bulletin of Experimental Biology and Medicine.

[25]  L. Wang,et al.  MicroRNA-140-5p inhibits invasion and angiogenesis through targeting VEGF-A in breast cancer , 2017, Cancer Gene Therapy.

[26]  Chunchun Zhao,et al.  Role of endothelial‐to‐mesenchymal transition induced by TGF‐β1 in transplant kidney interstitial fibrosis , 2017, Journal of cellular and molecular medicine.

[27]  A. Webster,et al.  Chronic Kidney Disease , 2017, The Lancet.

[28]  Xiaoping Zhou,et al.  Anti-Fibrosis Effect of Relaxin and Spironolactone Combined on Isoprenaline-Induced Myocardial Fibrosis in Rats via Inhibition of Endothelial–Mesenchymal Transition , 2017, Cellular Physiology and Biochemistry.

[29]  Meixiang Xiang,et al.  EphrinB2/EphB4 pathway in postnatal angiogenesis: a potential therapeutic target for ischemic cardiovascular disease , 2016, Angiogenesis.

[30]  K. Lai,et al.  Blocking TNF-α inhibits angiogenesis and growth of IFIT2-depleted metastatic oral squamous cell carcinoma cells. , 2016, Cancer letters.

[31]  T. Coffman,et al.  Tubulovascular cross-talk by vascular endothelial growth factor a maintains peritubular microvasculature in kidney. , 2015, Journal of the American Society of Nephrology : JASN.

[32]  R. Goldschmeding,et al.  Diverse origins of the myofibroblast—implications for kidney fibrosis , 2015, Nature Reviews Nephrology.

[33]  B. Ballermann,et al.  Tipping the balance from angiogenesis to fibrosis in CKD , 2014, Kidney international supplements.

[34]  J. Rak,et al.  Inflammatory Mediators of Angiogenesis , 2013, Mediators of inflammation.

[35]  B. Hinz,et al.  The myofibroblast matrix: implications for tissue repair and fibrosis , 2013, The Journal of pathology.

[36]  Satoru Miyano,et al.  Computational gene network analysis reveals TNF-induced angiogenesis , 2012, BMC Systems Biology.

[37]  T. Fujita,et al.  Angiotensin II- and salt-induced kidney injury through Rac1-mediated mineralocorticoid receptor activation. , 2012, Journal of the American Society of Nephrology : JASN.

[38]  B. Molitoris,et al.  Impaired endothelial proliferation and mesenchymal transition contribute to vascular rarefaction following acute kidney injury. , 2011, American journal of physiology. Renal physiology.

[39]  Yao Sun,et al.  Vascular endothelial growth factor (VEGF)-A: role on cardiac angiogenesis following myocardial infarction. , 2010, Microvascular research.

[40]  M. Rudnicki,et al.  Hypoxia response and VEGF-A expression in human proximal tubular epithelial cells in stable and progressive renal disease , 2009, Laboratory Investigation.

[41]  A. Lazaris,et al.  Hydronephrosis Promotes Expression of Hypoxia-Inducible Factor 1α , 2009, Urologia Internationalis.

[42]  Chul-woo Yang,et al.  Aldosterone-induced TGF-β1 Expression is Regulated by Mitogen-Activated Protein Kinases and Activator Protein-1 in Mesangial Cells , 2009, Journal of Korean medical science.

[43]  D. Basile,et al.  VEGF-121 preserves renal microvessel structure and ameliorates secondary renal disease following acute kidney injury. , 2008, American journal of physiology. Renal physiology.

[44]  Xueli Yuan,et al.  Endothelial-to-mesenchymal transition contributes to cardiac fibrosis , 2007, Nature Medicine.

[45]  Y. Mori,et al.  Mechanism for IL-1β-mediated Neovascularization Unmasked by IL-1βKnock-out Mice(Molecular Biology, Vascular 1 (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society) , 2004 .

[46]  P. Carmeliet.  Mechanisms of angiogenesis and arteriogenesis , 2000, Nature Medicine.

[47]  Takashi Suzuki,et al.  Pathology of Aldosterone Biosynthesis and its Action. , 2021, The Tohoku journal of experimental medicine.

[48]  M. Nagata,et al.  Increased expression of vascular endothelial growth factor in kidney leads to progressive impairment of glomerular functions. , 2007, Journal of the American Society of Nephrology : JASN.

[49]  H. Matsubara,et al.  Mechanism for IL-1 beta-mediated neovascularization unmasked by IL-1 beta knock-out mice. , 2004, Journal of molecular and cellular cardiology.